Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy

Alessia Di Silvestre, Marianna Lucafò, Sara De Iudicibus, Alessandro Ventura, Stefano Martelossi, Gabriele Stocco, Giuliana Decorti

Research output: Contribution to journalArticle

Abstract

Glucocorticoids (GCs) are largely used in different inflammatory, autoimmune and proliferative diseases. To date their mechanism of action is not completely clear and more studies are necessary, in particular to explain the great interindividual variability in clinical response. In this panorama the glucocorticoid receptor (GR) has an important role: in fact it regulates the pharmacological response thanks to the capability to interact with different molecules (DNA, RNA, ncRNA and proteins) that are known to influence its activity. In this review our aim is to highlight the knowledge about the role of protein-protein, RNA-protein interactions and epigenetic modifications on the GR and the consequent response to GCs. The characteristics of these interactions with the GR and their effects on the pharmacological activity of GCs will be examined. This information could contribute to the prediction of individual sensitivity to steroids through the identification of new markers of GC resistance. In addition this knowledge may be used in developing new strategies for targeted therapy.

Original languageEnglish
JournalMini-Reviews in Medicinal Chemistry
Publication statusE-pub ahead of print - Nov 29 2016

Fingerprint

Glucocorticoid Receptors
Drug Delivery Systems
Glucocorticoids
Drug Therapy
Proteins
Pharmacology
RNA
Epigenomics
Autoimmune Diseases
Steroids
DNA
Therapeutics

Keywords

  • Journal Article

Cite this

Glucocorticoid Receptor Interacting Co-regulators : Putative Candidates for Future Drug Targeting Therapy. / Di Silvestre, Alessia; Lucafò, Marianna; De Iudicibus, Sara; Ventura, Alessandro; Martelossi, Stefano; Stocco, Gabriele; Decorti, Giuliana.

In: Mini-Reviews in Medicinal Chemistry, 29.11.2016.

Research output: Contribution to journalArticle

@article{4da3bd348f9f46729b2100cf465aefa0,
title = "Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy",
abstract = "Glucocorticoids (GCs) are largely used in different inflammatory, autoimmune and proliferative diseases. To date their mechanism of action is not completely clear and more studies are necessary, in particular to explain the great interindividual variability in clinical response. In this panorama the glucocorticoid receptor (GR) has an important role: in fact it regulates the pharmacological response thanks to the capability to interact with different molecules (DNA, RNA, ncRNA and proteins) that are known to influence its activity. In this review our aim is to highlight the knowledge about the role of protein-protein, RNA-protein interactions and epigenetic modifications on the GR and the consequent response to GCs. The characteristics of these interactions with the GR and their effects on the pharmacological activity of GCs will be examined. This information could contribute to the prediction of individual sensitivity to steroids through the identification of new markers of GC resistance. In addition this knowledge may be used in developing new strategies for targeted therapy.",
keywords = "Journal Article",
author = "{Di Silvestre}, Alessia and Marianna Lucaf{\`o} and {De Iudicibus}, Sara and Alessandro Ventura and Stefano Martelossi and Gabriele Stocco and Giuliana Decorti",
year = "2016",
month = "11",
day = "29",
language = "English",
journal = "Mini-Reviews in Medicinal Chemistry",
issn = "1389-5575",
publisher = "Bentham Science Publishers B.V.",

}

TY - JOUR

T1 - Glucocorticoid Receptor Interacting Co-regulators

T2 - Putative Candidates for Future Drug Targeting Therapy

AU - Di Silvestre, Alessia

AU - Lucafò, Marianna

AU - De Iudicibus, Sara

AU - Ventura, Alessandro

AU - Martelossi, Stefano

AU - Stocco, Gabriele

AU - Decorti, Giuliana

PY - 2016/11/29

Y1 - 2016/11/29

N2 - Glucocorticoids (GCs) are largely used in different inflammatory, autoimmune and proliferative diseases. To date their mechanism of action is not completely clear and more studies are necessary, in particular to explain the great interindividual variability in clinical response. In this panorama the glucocorticoid receptor (GR) has an important role: in fact it regulates the pharmacological response thanks to the capability to interact with different molecules (DNA, RNA, ncRNA and proteins) that are known to influence its activity. In this review our aim is to highlight the knowledge about the role of protein-protein, RNA-protein interactions and epigenetic modifications on the GR and the consequent response to GCs. The characteristics of these interactions with the GR and their effects on the pharmacological activity of GCs will be examined. This information could contribute to the prediction of individual sensitivity to steroids through the identification of new markers of GC resistance. In addition this knowledge may be used in developing new strategies for targeted therapy.

AB - Glucocorticoids (GCs) are largely used in different inflammatory, autoimmune and proliferative diseases. To date their mechanism of action is not completely clear and more studies are necessary, in particular to explain the great interindividual variability in clinical response. In this panorama the glucocorticoid receptor (GR) has an important role: in fact it regulates the pharmacological response thanks to the capability to interact with different molecules (DNA, RNA, ncRNA and proteins) that are known to influence its activity. In this review our aim is to highlight the knowledge about the role of protein-protein, RNA-protein interactions and epigenetic modifications on the GR and the consequent response to GCs. The characteristics of these interactions with the GR and their effects on the pharmacological activity of GCs will be examined. This information could contribute to the prediction of individual sensitivity to steroids through the identification of new markers of GC resistance. In addition this knowledge may be used in developing new strategies for targeted therapy.

KW - Journal Article

M3 - Article

C2 - 27903230

JO - Mini-Reviews in Medicinal Chemistry

JF - Mini-Reviews in Medicinal Chemistry

SN - 1389-5575

ER -